查看購物車
  • English
  • Japanese
  • Korean
全球獸用寄生蟲防治市場：按類型、動物類型、最終用戶和地區分類－預測至2031年
市場調查報告書
商品編碼
2059330

全球獸用寄生蟲防治市場：按類型、動物類型、最終用戶和地區分類－預測至2031年

Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 439 Pages | 訂單完成後即時交付

價格

預計獸用寄生蟲控制劑的市場規模將從 2026 年的 129.8 億美元成長到 2031 年的 175 億美元，複合年成長率為 6.2%。

推動這一成長的因素包括長效治療方案和獸醫學中的精準寄生蟲管理，這些因素正在塑造寄生蟲預防的未來。

調查範圍
調查期 2024-2031
基準年 2025
預測期 2026-2031
目標單元 金額（10億美元）
部分 按類型、按動物類型、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

動物驅蟲市場最重要的促進因素之一是，獸醫專業人員不斷追求提高寄生蟲控制的準確性、速度和持久性，因此對更有效、更有針對性、更具預防性的寄生蟲控制策略的需求日益成長。隨著伴侶動物醫療保健行業的趨勢不斷向數據驅動和基於風險的寄生蟲控制方法發展，對能夠實現精準給藥、預防抗藥性和提供全年保護的高品質驅蟲劑的需求也日益成長。此外，分析技術和數位健康平台的應用進一步推動了這一趨勢，從而催生了對創新且安全的驅蟲產品的需求。

動物驅蟲藥市場-IMG1

隨著寵物寄生蟲感染、傳染病和老齡化相關疾病的日益增多，寵物飼主迫切需要快速、有效且持久的解決方案。獸醫透過使用先進的口服、外用和注射藥物治療更多患者，在提高治療效果的同時，也減少了患者的後續追蹤需求。寄生蟲抗藥性的加劇和環境寄生蟲污染迫使科學家研發新的活性成分和抗寄生蟲組合。

製劑科學和給藥系統的進步，例如緩釋注射劑、長效口服咀嚼片和改良的局部用藥製劑，透過提高療效、易用性和依從性，正在推動市場發展。這些進步使得有效的預防性治療成為可能，彌補了治療缺口，並改善了臨床療效，從而加速了獸醫寄生蟲防治市場創新解決方案的持續開發和應用。

“按動物種類分類，預計在預測期內，伴侶動物領域的複合年成長率將高於牲畜領域。”

受寵物飼主數量增加、寵物「擬人化」趨勢以及預防性獸醫保健支出成長的推動，伴侶動物領域預計將在動物寄生蟲防治市場中呈現高速成長。人們對寄生蟲傳播疾病的認知不斷提高，全年預防跳蚤、蜱蟲和心絲蟲病的措施，以及創新型長效寄生蟲防治產品的普及，都進一步推動了該領域的需求。

“按終端用戶細分市場來看，預計到 2025 年，獸醫醫院和診所細分市場將佔據最大的市場佔有率。”

2025年，獸醫院和診所佔據了動物驅蟲藥市場的主導地位，因為這些機構憑藉其診斷和處方能力，成為提供驅蟲治療的主要中心。寵物飼主和畜牧養殖戶依賴獸醫提供專業的產品建議和預防保健方案，這推動了獸醫醫院和診所驅蟲藥銷售的成長。處方箋藥和先進長效產品的結合，以及對常規檢查和預防保健日益成長的需求，使獸醫醫院和診所成為市場上的主要分銷和治療管道。

“預計拉丁美洲在預測期內將呈現最高的成長率。”

在預測期內，拉丁美洲有望成為動物驅蟲市場成長最快的區域市場。該地區市場的高成長率歸因於畜牧業規模的擴大、伴侶動物數量的增加以及人們對寄生蟲預防和動物健康意識的提高。該地區的氣候為寄生蟲的全年繁殖提供了適宜的環境，獸醫服務的普及以及最新驅蟲劑的廣泛應用，都是推動拉丁美洲市場成長的因素。

調查範圍

本市場研究涵蓋動物寄生蟲防治市場的各個細分市場。研究旨在按類型、目標動物、最終用戶和地區評估該市場的規模和成長潛力。除了對市場主要參與者進行詳細的競爭分析外，本研究還包括公司簡介、產品類型和營業內容的關鍵觀察、近期趨勢以及各公司的主要市場策略。

購買本報告的理由

本報告將幫助成熟企業和新興企業/中小企業了解市場趨勢，並擴大市場佔有率。獲得本報告的企業可以實施以下五項策略中的一項或多項。

本報告深入分析了以下幾點：

  • 本報告分析了關鍵促進因素（寵物飼養量的增加、對預防性獸醫學的日益重視以及體內外寄生蟲的傳播）、阻礙因素（對肉類動物中殺蟲劑殘留的嚴格規定以及高級產品和復方殺蟲劑產品的高成本）、機遇（長效、複方和新型驅蟲藥給藥途徑的開發以及驅蟲藥在新興市場的滲透率提高）和挑戰（寄生蟲對現有活性成分的抗藥性不斷增強、嚴格的監管審蟲流程以及合規要求的區域差異），以確定影響獸用驅蟲藥市場成長的因素。
  • 產品開發/創新：對動物驅蟲藥市場的未來技術趨勢和新產品發布進行詳細分析。
  • 市場發展：提供新興盈利市場的全面資訊。本報告按產品類型和地區分析了各種動物寄生蟲防治產品的市場趨勢。
  • 市場多元化：提供動物寄生蟲防治市場的產品、未開發地區、最新趨勢和投資方面的全面資訊。
  • 競爭分析：對動物寄生蟲防治市場主要參與者的市場佔有率、策略、產品、分銷網路和生產能力進行詳細評估。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 總體經濟指標
  • 價值鏈分析
  • 生態系分析
  • 價格分析
  • 貿易分析
  • 2026-2027 年主要會議和活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 動物寄生蟲防治市場：2025年美國關稅的影響

第6章：透過採用技術、專利、數位技術和人工智慧實現策略顛覆

  • 技術分析
  • 技術/產品藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對動物寄生蟲防治市場的影響

第7章：顧客趨勢與購買行為

  • 決策流程
  • 主要相關人員和採購評估標準
  • 實施障礙和內部挑戰
  • 各種終端使用者環境中的未滿足需求
  • 市場盈利

第8章永續性和監管情勢

  • 監理情勢
  • 對永續性的承諾

第9章：獸用寄生蟲控制劑市場（按類型分類）

  • 體外寄生蟲控制劑
  • 體內寄生蟲控制劑
  • 腸道寄生蟲驅避劑

第10章：獸用寄生蟲控制劑市場（依動物類型分類）

  • 伴侶動物
  • 家畜

第11章：獸用寄生蟲控制劑市場（依最終用戶分類）

  • 動物醫院和動物診所
  • 畜牧場
  • 居家護理設施

第12章：動物寄生蟲防治劑市場（依地區分類）

  • 北美洲
    • 北美宏觀經濟展望
    • 北美：獸用寄生蟲防治市場依產品類型分類的銷售量分析（2024-2031 年）（千單位）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 歐洲：獸用寄生蟲防治市場依產品類型分類的銷售量分析（2024-2031 年）（千單位）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區
    • 亞太地區宏觀經濟展望
    • 亞太地區：獸用寄生蟲防治市場依產品類型分類的銷售量分析（2024-2031 年）（千單位）
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 紐西蘭
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 拉丁美洲：獸用寄生蟲防治市場按產品類型分類的銷售量分析（2024-2031 年）（千單位）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 中東和非洲：按產品類型分類的動物寄生蟲防治市場銷售量分析（2024-2031 年）（千單位）
  • 海灣合作理事會國家
    • 沙烏地阿拉伯王國（KSA）
    • 阿拉伯聯合大公國（阿拉伯聯合大公國）
    • 其他海灣合作理事會國家
    • 其他

第13章 競爭格局

  • 2023-2025年收入分析
  • 2025年全球市佔率分析
  • 企業估值矩陣：主要公司，2024 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 產品/品牌對比
  • 競爭格局和趨勢

第14章：公司簡介

  • 主要參與企業
    • ZOETIS INC.
    • MERCK & CO., INC
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • ELANCO
    • VIRBAC
    • CEVA
    • VETOQUINOL
    • NORBROOK
    • BIMEDA CORPORATE
    • KYORITSU SEIYAKU CORPORATION
    • KRKA, DD, NOVO MESTO
    • ECO-ANIMAL HEALTH LTD.
    • ALIVIRA ANIMAL HEALTH LIMITED
    • OUROFINO SAUDE ANIMAL
    • HEBEI VEYONG PHARMACEUTICAL CO., LTD.
  • 其他公司
    • CHANELLE PHARMA
    • PETIQ LLC
    • HUVEPHARMA
    • CALIER
    • ABBEY LABS
    • BIOGENESIS BAGO
    • VETANCO SA
    • HESTER BIOSCIENCES LIMITED
    • BRILLIANT BIO PHARMA
    • ASHISH LIFE SCIENCE

第15章：調查方法

第16章附錄

Product Code: PH 2460

The animal parasiticides market is expected to grow from USD 12.98 billion in 2026 to USD 17.50 billion by 2031, at a CAGR of 6.2%. This growth is driven by several key factors shaping the future of parasite prevention, including long-acting treatment solutions and precision-driven parasite management in veterinary care.

Scope of the Report
Years Considered for the Study2024-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsBy Type, Animal Type, End User, Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

One of the most significant driving forces in the animal parasiticides market is the growing demand for more effective, targeted, and preventive parasite control strategies as veterinary healthcare professionals work to improve the accuracy, speed, and longevity of parasite control. As the trend in the companion animal healthcare industry continues to evolve to a data-driven and risk-based approach to parasite control, there is an increasing demand for high-quality parasiticides that can support precision dosing, resistance, and year-round protection. This has been further fueled by the use of analytics and digital health platforms, thus creating a demand for innovative and safe parasiticide products.

Animal Parasiticides Market - IMG1

Pet owners face urgent demand for fast-acting, effective, and long-lasting solutions because parasite infestations, vector-borne diseases, and age-related pet vulnerability keep increasing in frequency. Veterinarians use advanced oral, topical, and injectable products to treat more patients while achieving better treatment results through reduced need for patient follow-ups. The rising parasite resistance problem and environmental parasite contamination issue compel scientists to develop new active ingredients and combination parasiticides for their research.

Formulation science and delivery system advancements, such as extended-release injectables, long-acting oral chewables, and enhanced topical formulations, are driving the market as they enhance efficacy, ease of use, and compliance. Such advancements enable effective preventive treatment, close treatment gaps, and improve real-world outcomes, thus accelerating the ongoing development and adoption of innovative solutions in the animal parasiticides market.

"By animal type, the companion animals segment is projected to exhibit a higher CAGR than the livestock segment during the forecast period."

The companion animals segment is expected to experience a high growth rate in the animal parasiticides market because of the rising number of pet owners, the increasing humanization of pets, and increased expenditures on preventive veterinary care. The growing awareness of parasite-borne diseases, combined with the strong adoption of year-round flea, tick, and heartworm prevention and innovative long-acting parasiticide products, has also fueled demand in this segment.

"By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025."

In 2025, the veterinary hospitals & clinics segment dominated the animal parasiticides market because these facilities served as the main center for parasite control treatment delivery through their diagnostic and prescription capabilities. Pet owners and livestock producers depend on veterinarians to deliver expert product advice and preventive care solutions, which leads to increased sales of parasiticides at veterinary clinics. The combination of prescription-only products and advanced long-acting products, together with rising demand for routine check-ups and preventive care, has established veterinary hospitals and clinics as the primary distribution and treatment channel in the market.

"Latin America is expected to witness the highest growth rate during the forecast period."

Latin America is projected to be the fastest-growing regional market for animal parasiticides during the forecast period. The region's high market growth can be attributed to the expansion of livestock production, the increase in companion animal ownership, and a growing awareness of parasite prevention and animal health. Year-round favorable parasite living conditions due to the region's climate, enhanced availability of veterinary services, and increased use of modern parasiticide products are all factors that are speeding up the market growth in the Latin American region.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
  • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
  • By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

  • By End User: Veterinary Hospitals & Clinics (50%), Animal Farms (33%), and Home Care Settings (17%)

By Designation: Veterinarian/Chief Veterinary Officer (47%), Procurement/Purchasing Manager (22%), Head of Animal Health / Farm Manager (15%), and Others (16%)

  • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the animal parasiticides market in various segments. It aims to estimate the size and growth potential of this market by type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

  • Analysis of key drivers (rising pet ownership and increased focus on preventive animal healthcare and growing prevalence of ecto- and endoparasites), restraints (strict regulations on parasiticide residues in food-producing animals and high cost of premium and combination parasiticide products), opportunities (development of long-acting, combination, and novel-delivery parasiticides and expansion of parasiticide adoption in emerging markets), and challenges (increasing parasite resistance to existing active ingredients and stringent regulatory approval processes and varying regional compliance requirements) influencing the growth of the animal parasiticides market.
  • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the animal parasiticides market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of animal parasiticide products across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal parasiticides market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal parasiticides market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN ANIMAL PARASITICIDES MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ANIMAL PARASITICIDES MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2025)
  • 3.3 ANIMAL PARASITICIDES MARKET: REGIONAL GROWTH OPPORTUNITIES
  • 3.4 ANIMAL PARASITICIDES MARKET: REGION (2026-2031)
  • 3.5 ANIMAL PARASITICIDES MARKET: DEVELOPED VS. DEVELOPING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing zoonotic & vector-borne disease burden, creating mandatory treatment
      • 4.2.1.2 Expanding companion animal population and pet ownership
      • 4.2.1.3 Increasing demand for animal-derived food products
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Growing resistance to parasiticides
      • 4.2.2.2 Stringent regulatory approval processes for veterinary drugs
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 High growth potential of emerging economies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Uneven regulatory approval timelines across key markets, creating access inequalities
      • 4.2.4.2 Balancing animal welfare, productivity, and compliance requirements
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCE ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS)
    • 5.2.4 GDP: CURRENT PRICES (USD BILLION)
    • 5.2.5 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
    • 5.2.6 TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY KEY PLAYER, 2023-2025
      • 5.5.1.1 Average selling price trend of ectoparasiticides, by key player, 2023-2025
      • 5.5.1.2 Average selling price trend of endoparasiticides, by key player, 2023-2025
      • 5.5.1.3 Average selling price trend of endectocides, by key player, 2023-2025
    • 5.5.2 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023-2025
      • 5.5.2.1 Average selling price trend of pour-on ectoparasiticides (USD per standard treatment unit), by region, 2023-2025
      • 5.5.2.2 Average selling price trend of spray ectoparasiticides (USD per standard treatment unit), by region, 2023-2025
      • 5.5.2.3 Average selling price trend of tablet ectoparasiticides (USD per standard treatment unit), by region, 2023-2025
      • 5.5.2.4 Average selling price trend of endoparasiticide oral solids (USD per standard treatment unit), by region, 2023-2025
      • 5.5.2.5 Average selling price trend of injectable endectocides (USD per standard treatment unit), by region, 2023-2025
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT DATA FOR HS CODE 30, 2021-2025
    • 5.6.2 IMPORT SCENARIO (HS CODE 30)
    • 5.6.3 EXPORT DATA FOR HS CODE 30, 2021-2025
    • 5.6.4 EXPORT SCENARIO (HS CODE 30)
  • 5.7 KEY CONFERENCES AND EVENTS IN 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS - SIMPARICA TRIO)
    • 5.10.2 CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM - NEXGARD COMBO)
    • 5.10.3 CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO - CREDELIO QUATTRO)
  • 5.11 ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRY/REGION
    • 5.11.5 IMPACT ON END USERS
      • 5.11.5.1 Veterinary hospitals & clinics
      • 5.11.5.2 Home care settings
      • 5.11.5.3 Animal farms

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY EMERGING TECHNOLOGIES
      • 6.1.1.1 Long-acting/Extended-release parasiticides
      • 6.1.1.2 Novel multi-parasite combination therapies
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Immunomodulators for host-assisted parasitic control
      • 6.1.2.2 Nanobiosensors and rapid diagnostics for parasitic detection
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Entomopathogenic Fungi (EPF) for ticks and ectoparasites
      • 6.1.3.2 Precision livestock farming sensors and wearables
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3 PATENT ANALYSIS
    • 6.3.1 PUBLICATION TRENDS FOR ANIMAL PARASITICIDES
      • 6.3.1.1 Insights on patent publication trends, top applicants and jurisdiction for animal parasiticides, january 2015-may 2026
    • 6.3.2 LIST OF MAJOR PATENTS, 2023-2026
  • 6.4 FUTURE APPLICATIONS
    • 6.4.1 PRECISION LIVESTOCK HEALTH MANAGEMENT
    • 6.4.2 ONCOLOGY AND CHRONIC DISEASE MANAGEMENT
    • 6.4.3 REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK
    • 6.4.4 INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL
  • 6.5 IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET
    • 6.5.1 INTRODUCTION
    • 6.5.2 MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM
    • 6.5.3 AI USE CASES
    • 6.5.4 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 7.1 DECISION-MAKING PROCESS
  • 7.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 7.2.2 BUYING CRITERIA
  • 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 7.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS
    • 7.4.1 VETERINARY HOSPITALS & CLINICS
    • 7.4.2 LIVESTOCK FARMS
    • 7.4.3 HOME CARE SETTINGS
  • 7.5 MARKET PROFITABILITY
    • 7.5.1 PRODUCT INNOVATION AND DIFFERENTIATION
    • 7.5.2 EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING
    • 7.5.3 OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY

8 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 8.1 REGULATORY LANDSCAPE
    • 8.1.1 REGULATORY FRAMEWORK
      • 8.1.1.1 North America
      • 8.1.1.2 Europe
    • 8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 8.1.3 INDUSTRY STANDARDS
      • 8.1.3.1 VICH Guidelines (International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products)
      • 8.1.3.2 Good Manufacturing Practice (GMP) Standards - PIC/S Guide (PE 009 series)
      • 8.1.3.3 Codex Alimentarius Standards for Veterinary Drug Residues (CXM 2 - Maximum Residue Limits)
  • 8.2 SUSTAINABILITY INITIATIVES
    • 8.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET
    • 8.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
    • 8.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

9 ANIMAL PARASITICIDES MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 ECTOPARASITICIDES
    • 9.2.1 POUR-ONS & SPOT-ONS
      • 9.2.1.1 Ease of application and broad spectrum activity to drive continued adoption
      • 9.2.1.2 Global volume analysis of pour-ons & spot-ons, 2024-2031 (Thousand Units)
    • 9.2.2 ORAL TABLETS
      • 9.2.2.1 High medication compliance and ease of administration to drive market
      • 9.2.2.2 Global Volume Analysis of oral tablets, 2024-2031 (Thousand Units)
    • 9.2.3 SPRAYS
      • 9.2.3.1 Low price and convenience to drive market in emerging economies and livestock sector
      • 9.2.3.2 Global Volume Analysis of sprays, 2024-2031 (Thousand Units)
    • 9.2.4 DIPS
      • 9.2.4.1 High popularity ensures sustained end-user demand
      • 9.2.4.2 Global Volume Analysis of DIPS, 2024-2031 (Thousand Units)
    • 9.2.5 EAR TAGS
      • 9.2.5.1 High effectiveness in controlling flies around cattle drives market
      • 9.2.5.2 Global Volume Analysis of ear tags, 2024-2031 (Thousand Units)
    • 9.2.6 COLLARS
      • 9.2.6.1 Growing prevalence of infections in companion animals to drive adoption
      • 9.2.6.2 Global Volume Analysis of collars market, 2024-2031 (Thousand Units)
    • 9.2.7 OTHER ECTOPARASITICIDES
  • 9.3 ENDOPARASITICIDES
    • 9.3.1 ORAL LIQUIDS
      • 9.3.1.1 Broad-spectrum activity to drive adoption across young animals and intensive livestock systems
      • 9.3.1.2 Global volume analysis of oral liquids, 2024-2031 (Thousand Units)
    • 9.3.2 ORAL SOLIDS
      • 9.3.2.1 Emergence of internal parasitic infections in dogs to drive market
      • 9.3.2.2 Global volume analysis of oral solids, 2024-2031 (Thousand Units)
    • 9.3.3 INJECTABLES
      • 9.3.3.1 Global volume analysis of injectables, 2024-2031 (Thousand Units)
      • 9.3.3.2 Standard/Short-acting injectables
        • 9.3.3.2.1 Veterinary preference for fast-acting injectable formulations in acute parasitic infections drives market growth
      • 9.3.3.3 Long-acting/Extended-release injectables
        • 9.3.3.3.1 Emergence of internal parasitic infections in dogs to drive market
    • 9.3.4 FEED ADDITIVES
      • 9.3.4.1 Can be administered to large number of animals at once
      • 9.3.4.2 Global volume analysis of feed additives, 2024-2031 (Thousand Units)
    • 9.3.5 OTHER ENDOPARASITICIDES
  • 9.4 ENDECTOCIDES
    • 9.4.1 ORAL ENDECTOCIDES
      • 9.4.1.1 Growing pet owner preference for systemic all-in-one protection to accelerate oral endectocide demand
      • 9.4.1.2 Global volume analysis of oral endectocides, 2024-2031 (Thousand Units)
    • 9.4.2 INJECTABLE ENDECTOCIDES
      • 9.4.2.1 Single-injection dual-action convenience underpins dominance in cattle and swine production systems
      • 9.4.2.2 Global volume analysis of injectable endectocides, 2024-2031 (Thousand Units)
    • 9.4.3 TOPICAL ENDECTOCIDES
      • 9.4.3.1 Convenience, zero-injection compliance, and expanding multi-spectrum topical formulations sustain demand
      • 9.4.3.2 Global volume analysis of topical endectocides, 2024-2031 (Thousand Units)

10 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE

  • 10.1 INTRODUCTION
  • 10.2 COMPANION ANIMALS
    • 10.2.1 DOGS
      • 10.2.1.1 Increasing adoption of dogs to drive market growth
    • 10.2.2 CATS
      • 10.2.2.1 Rising feline parasiticide adoption, low preventive compliance, and broad-spectrum product launches drive growth
    • 10.2.3 HORSES
      • 10.2.3.1 Higher risk of traumatic injuries in horses to drive demand
    • 10.2.4 OTHER COMPANION ANIMALS
  • 10.3 LIVESTOCK ANIMALS
    • 10.3.1 CATTLE
      • 10.3.1.1 Gastrointestinal nematodes and tick-borne disease drive systemic endectocide and acaricide demand
    • 10.3.2 PIG
      • 10.3.2.1 Growing surgical volume for acute conditions in swine to drive market growth
    • 10.3.3 POULTRY
      • 10.3.3.1 Growing focus on infection prevention and flock health management propels growth
    • 10.3.4 SHEEP & GOAT
      • 10.3.4.1 Growth in consumption of sheep and goat meat to drive market
    • 10.3.5 OTHER LIVESTOCK ANIMALS

11 ANIMAL PARASITICIDES MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 VETERINARY HOSPITALS & CLINICS
    • 11.2.1 VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
  • 11.3 ANIMAL FARMS
    • 11.3.1 GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT
  • 11.4 HOME CARE SETTINGS
    • 11.4.1 RISING PET EXPENDITURE TO PROPEL MARKET GROWTH

12 ANIMAL PARASITICIDES MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
    • 12.2.3 US
      • 12.2.3.1 Surge in animal healthcare expenditure to boost market growth
    • 12.2.4 CANADA
      • 12.2.4.1 Growing pet ownership and increasing focus on preventive animal healthcare to drive market growth
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
    • 12.3.3 GERMANY
      • 12.3.3.1 Strong focus on animal welfare and advanced veterinary care to drive market growth
    • 12.3.4 UK
      • 12.3.4.1 Increasing pet ownership and rising animal healthcare spending to propel market growth
    • 12.3.5 FRANCE
      • 12.3.5.1 High standards of veterinary care and technological advancements to support market growth
    • 12.3.6 ITALY
      • 12.3.6.1 Growing pet ownership awareness and increasing livestock population to drive market growth
    • 12.3.7 SPAIN
      • 12.3.7.1 Increasing awareness regarding animal health to drive market growth
    • 12.3.8 NETHERLANDS
      • 12.3.8.1 Growing pet ownership and strong livestock sector to support market growth
    • 12.3.9 SWEDEN
      • 12.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth
    • 12.3.10 POLAND
      • 12.3.10.1 Rapid expansion of poultry production and export-oriented farming increases demand
    • 12.3.11 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
    • 12.4.3 CHINA
      • 12.4.3.1 China to register highest growth rate during forecast period
    • 12.4.4 JAPAN
      • 12.4.4.1 Rising pet care expenditure and increasing adoption of companion animals to drive market growth
    • 12.4.5 INDIA
      • 12.4.5.1 Increasing livestock population to propel market growth
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Growing companion animal ownership and rise in animal health awareness to support market growth
    • 12.4.7 SOUTH KOREA
      • 12.4.7.1 Growing pet ownership to favor growth
    • 12.4.8 THAILAND
      • 12.4.8.1 Growing focus on livestock health and disease prevention to drive market growth
    • 12.4.9 NEW ZEALAND
      • 12.4.9.1 Growing pet ownership and focus on preventive animal healthcare to support market growth
    • 12.4.10 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
    • 12.5.3 BRAZIL
      • 12.5.3.1 Brazil to dominate Latin American market
    • 12.5.4 MEXICO
      • 12.5.4.1 Robust livestock base and growing companion animal care drive market
    • 12.5.5 ARGENTINA
      • 12.5.5.1 Expanding livestock production and increasing focus on disease prevention to drive market growth
    • 12.5.6 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • 12.7 GCC COUNTRIES
    • 12.7.1 KINGDOM OF SAUDI ARABIA (KSA)
      • 12.7.1.1 Market growth driven by Vision 2030 investments
    • 12.7.2 UNITED ARAB EMIRATES (UAE)
      • 12.7.2.1 Increasing focus on livestock health and companion animal care to support market growth
    • 12.7.3 OTHER GCC COUNTRIES
    • 12.7.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
    • 13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET
  • 13.2 REVENUE ANALYSIS, 2023-2025
  • 13.3 GLOBAL MARKET SHARE ANALYSIS, 2025
    • 13.3.1 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
    • 13.3.2 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
  • 13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.4.1 STARS
    • 13.4.2 EMERGING LEADERS
    • 13.4.3 PERVASIVE PLAYERS
    • 13.4.4 PARTICIPANTS
    • 13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 13.4.5.1 Company footprint
      • 13.4.5.2 Region footprint
      • 13.4.5.3 Product type footprint
      • 13.4.5.4 Animal type footprint
  • 13.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 13.5.1 PROGRESSIVE COMPANIES
    • 13.5.2 RESPONSIVE COMPANIES
    • 13.5.3 DYNAMIC COMPANIES
    • 13.5.4 STARTING BLOCKS
    • 13.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 13.5.5.1 List of startups/SMEs
      • 13.5.5.2 Competitive benchmarking of startups/SMEs
  • 13.6 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.7 PRODUCT/BRAND COMPARISON
  • 13.8 COMPETITIVE SITUATIONS & TRENDS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 ZOETIS INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches & approvals
        • 14.1.1.3.2 Expansions
        • 14.1.1.3.3 Other developments
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 MERCK & CO., INC
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product launches & approvals
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches & approvals
        • 14.1.3.3.2 Deals
        • 14.1.3.3.3 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 ELANCO
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches & approvals
        • 14.1.4.3.2 Expansions
        • 14.1.4.3.3 Other developments
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Right to win
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses and competitive threats
    • 14.1.5 VIRBAC
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product launches & approvals
        • 14.1.5.3.2 Deal
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Right to win
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 CEVA
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
        • 14.1.6.3.2 Expansions
    • 14.1.7 VETOQUINOL
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
    • 14.1.8 NORBROOK
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches & approvals
        • 14.1.8.3.2 Expansions
    • 14.1.9 BIMEDA CORPORATE
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Product launches & approvals
        • 14.1.9.3.2 Deals
        • 14.1.9.3.3 Expansions
    • 14.1.10 KYORITSU SEIYAKU CORPORATION
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
    • 14.1.11 KRKA, D. D., NOVO MESTO
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
    • 14.1.12 ECO - ANIMAL HEALTH LTD.
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
    • 14.1.13 ALIVIRA ANIMAL HEALTH LIMITED
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products offered
        • 14.1.13.2.1 Recent developments
        • 14.1.13.2.2 Deals
    • 14.1.14 OUROFINO SAUDE ANIMAL
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products offered
    • 14.1.15 HEBEI VEYONG PHARMACEUTICAL CO., LTD.
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 CHANELLE PHARMA
    • 14.2.2 PETIQ LLC
    • 14.2.3 HUVEPHARMA
    • 14.2.4 CALIER
    • 14.2.5 ABBEY LABS
    • 14.2.6 BIOGENESIS BAGO
    • 14.2.7 VETANCO SA
    • 14.2.8 HESTER BIOSCIENCES LIMITED
    • 14.2.9 BRILLIANT BIO PHARMA
    • 14.2.10 ASHISH LIFE SCIENCE

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH APPROACH
  • 15.2 RESEARCH METHODOLOGY DESIGN
    • 15.2.1 SECONDARY RESEARCH
      • 15.2.1.1 Key data from secondary sources
    • 15.2.2 PRIMARY DATA
      • 15.2.2.1 Key data from primary sources
      • 15.2.2.2 Key industry insights
  • 15.3 MARKET SIZE ESTIMATION
    • 15.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 15.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 15.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS
    • 15.3.4 APPROACH 4: TOP-DOWN APPROACH
    • 15.3.5 APPROACH 5: BOTTOM-UP APPROACH
  • 15.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 15.5 MARKET SHARE ESTIMATION
  • 15.6 RESEARCH ASSUMPTIONS
  • 15.7 RISK ASSESSMENT
  • 15.8 RESEARCH LIMITATIONS
    • 15.8.1 METHODOLOGY-RELATED LIMITATIONS
    • 15.8.2 SCOPE-RELATED LIMITATIONS

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
    • 16.3.1 PRODUCT ANALYSIS
    • 16.3.2 COMPANY INFORMATION
    • 16.3.3 GEOGRAPHIC ANALYSIS
    • 16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
    • 16.3.5 BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
    • 16.3.6 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
  • TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2025
  • TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION
  • TABLE 4 TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED & EMERGING ECONOMIES
  • TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 7 PARASITICIDES AND RESISTANT PARASITES
  • TABLE 8 UNMET CUSTOMER NEEDS AND WHITE SPACES IN ANIMAL PARASITICIDES MARKET.
  • TABLE 9 INTERCONNECTED MARKETS IN ANIMAL PARASITICIDES MARKET
  • TABLE 10 CROSS-SECTOR MARKETS IN ANIMAL PARASITICIDES MARKET
  • TABLE 11 ANIMAL PARASITICIDES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 12 AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES, BY KEY PLAYER, 2023-2025
  • TABLE 13 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES, BY KEY PLAYER, 2023-2025
  • TABLE 14 AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023-2025
  • TABLE 15 AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES, BY REGION, 2023-2025
  • TABLE 16 AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES, BY REGION, 2023-2025
  • TABLE 17 AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES, BY REGION, 2023-2025
  • TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS, BY REGION, 2023-2025
  • TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES, BY REGION, 2023-2025
  • TABLE 20 IMPORT DATA FOR HS CODE 30, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 21 EXPORT DATA FOR HS CODE 30, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 22 ANIMAL PARASITICIDES MARKET: KEY CONFERENCES AND EVENTS
  • TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 24 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
  • TABLE 25 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
  • TABLE 26 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
  • TABLE 27 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
  • TABLE 28 ANIMAL PARASITICIDES MARKET: MAJOR PATENTS, JANUARY 2022-MAY 2026
  • TABLE 29 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET
  • TABLE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDES
  • TABLE 31 KEY BUYING CRITERIA FOR CLASS OF DEVICES
  • TABLE 32 ANIMAL PARASITICIDES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS
  • TABLE 33 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 34 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 35 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 36 REST OF WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 37 ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 38 COMPANION ANIMALS - FLEA & TICK BURDEN
  • TABLE 39 ECTOPARASITICIDES AVAILABLE IN MARKET
  • TABLE 40 ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 41 ECTOPARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 KEY PLAYERS PROVIDING POUR-ONS & SPOT-ONS
  • TABLE 43 GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024-2031 (THOUSAND UNITS)
  • TABLE 44 POUR-ONS & SPOT-ONS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 KEY PLAYERS PROVIDING ORAL TABLETS
  • TABLE 46 GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024-2031 (THOUSAND UNITS)
  • TABLE 47 ORAL TABLETS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 KEY PLAYERS PROVIDING SPRAYS
  • TABLE 49 GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024-2031 (THOUSAND UNITS)
  • TABLE 50 SPRAYS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 KEY PLAYERS PROVIDING DIPS
  • TABLE 52 GLOBAL VOLUME ANALYSIS OF DIPS, 2024-2031 (THOUSAND UNITS)
  • TABLE 53 DIPS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 KEY PLAYERS PROVIDING TAGS
  • TABLE 55 GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024-2031 (THOUSAND UNITS)
  • TABLE 56 EARTAG: ANIMAL PARASITICIDES TAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 KEY PLAYERS PROVIDING COLLARS
  • TABLE 58 GLOBAL VOLUME ANALYSIS OF COLLARS MARKET, 2024-2031 (THOUSAND UNITS)
  • TABLE 59 COLLARS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 ENDOPARASITICIDES AVAILABLE IN MARKET
  • TABLE 62 ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 63 ENDOPARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 64 KEY PLAYERS PROVIDING ORAL LIQUIDS
  • TABLE 65 GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024-2031 (THOUSAND UNITS)
  • TABLE 66 ORAL LIQUIDS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 KEY PLAYERS PROVIDING ORAL SOLIDS
  • TABLE 68 GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024-2031 (THOUSAND UNITS)
  • TABLE 69 ORAL: ANIMAL PARASITICIDES SOLIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024-2031 (THOUSAND UNITS)
  • TABLE 71 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 72 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 KEY PLAYERS PROVIDING STANDARD/SHORT-ACTING INJECTABLES
  • TABLE 74 STANDARD/SHORT-ACTING INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 KEY PLAYERS PROVIDING LONG-ACTING/EXTENDED-RELEASE INJECTABLES
  • TABLE 76 LONG-ACTING/EXTENDED-RELEASE INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 KEY PLAYERS PROVIDING FEED ADDITIVES
  • TABLE 78 GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024-2031 (THOUSAND UNITS)
  • TABLE 79 FEED ADDITIVES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
  • TABLE 82 ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 83 ENDECTOCIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 KEY PLAYERS PROVIDING ORAL ENDECTOCIDES
  • TABLE 85 GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES, 2024-2031 (THOUSAND UNITS)
  • TABLE 86 ORAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 KEY PLAYERS PROVIDING INJECTABLE ENDECTOCIDES
  • TABLE 88 GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES, 2024-2031 (THOUSAND UNITS)
  • TABLE 89 INJECTABLE ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 KEY PLAYERS PROVIDING TOPICAL ENDECTOCIDES
  • TABLE 91 GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES, 2024-2031 (THOUSAND UNITS)
  • TABLE 92 TOPICAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 93 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 94 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 95 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 PARASITICIDE APPLICATIONS ACROSS OTHER COMPANION ANIMAL SPECIES
  • TABLE 100 ANIMAL PARASITICIDES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 103 ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 104 ANIMAL PARASITICIDES MARKET FOR PIG, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 ANIMAL PARASITICIDES MARKET FOR SHEEP & GOAT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 ANIMAL PARASITICIDES MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 108 ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 109 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 110 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 ANIMAL PARASITICIDES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 113 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 114 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 116 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 NORTH AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 121 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 122 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 123 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 124 US: KEY MACROINDICATORS
  • TABLE 125 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 126 US: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 US: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 128 US: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 US: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 US: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 132 US: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 133 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 134 CANADA: KEY MACROINDICATORS
  • TABLE 135 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 137 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 138 CANADA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 CANADA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 CANADA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 142 CANADA ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 143 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 144 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 145 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 152 EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 153 EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 154 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 155 GERMANY: KEY MACROINDICATORS
  • TABLE 156 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 158 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 GERMANY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 GERMANY: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 161 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 162 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 163 GERMANY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 164 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 165 UK: KEY MACROINDICATORS
  • TABLE 166 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 168 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 UK: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 UK: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 171 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 172 UK: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 173 UK: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 174 UK ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 175 FRANCE: KEY MACROINDICATORS
  • TABLE 176 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 178 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 FRANCE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 180 FRANCE: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 FRANCE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 183 FRANCE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 184 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 185 ITALY: KEY MACROINDICATORS
  • TABLE 186 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 ITALY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 ITALY: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 192 ITALY: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 193 ITALY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 194 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 195 SPAIN: KEY MACROINDICATORS
  • TABLE 196 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 SPAIN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 SPAIN: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 201 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 SPAIN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 203 SPAIN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 204 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 205 NETHERLANDS: KEY MACROINDICATORS
  • TABLE 206 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 NETHERLANDS: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 208 NETHERLANDS: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 NETHERLANDS: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 213 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 214 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 215 SWEDEN: KEY MACRO INDICATORS
  • TABLE 216 SWEDEN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 217 SWEDEN: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 218 SWEDEN: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 SWEDEN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 SWEDEN: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 SWEDEN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 SWEDEN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 223 SWEDEN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 224 SWEDEN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 225 POLAND: KEY MACRO INDICATORS
  • TABLE 226 POLAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 POLAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 228 POLAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 229 POLAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 POLAND: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 POLAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 POLAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 233 POLAND ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 234 POLAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 235 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 236 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 REST OF EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 241 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 242 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 243 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 245 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 251 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 255 CHINA: KEY MACROINDICATORS
  • TABLE 256 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 CHINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 CHINA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 261 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 262 CHINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 263 CHINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 264 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 265 JAPAN: KEY MACROINDICATORS
  • TABLE 266 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 JAPAN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 JAPAN: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 272 JAPAN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 273 JAPAN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 274 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 275 INDIA: KEY MACROINDICATORS
  • TABLE 276 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 277 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 278 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 INDIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 INDIA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 282 INDIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 283 INDIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 284 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 285 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 286 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 AUSTRALIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 AUSTRALIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 289 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 290 AUSTRALIA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 293 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 294 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 295 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 296 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 300 SOUTH KOREA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 301 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 302 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 303 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 304 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 305 THAILAND: KEY MACROINDICATORS
  • TABLE 306 THAILAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 307 THAILAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 308 THAILAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 THAILAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 THAILAND: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 311 THAILAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 312 THAILAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 313 THAILAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 314 THAILAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 315 NEW ZEALAND: KEY MACROINDICATORS
  • TABLE 316 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 318 NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 NEW ZEALAND: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 323 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 324 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 325 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 326 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 327 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 REST OF ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 334 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 335 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 336 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 339 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 340 LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 342 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 343 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 344 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 345 BRAZIL: KEY MACROINDICATORS
  • TABLE 346 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 BRAZIL: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 350 BRAZIL: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 351 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 BRAZIL: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 353 BRAZIL: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 354 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 355 MEXICO: KEY MACROINDICATORS
  • TABLE 356 MEXICO: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 MEXICO: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 MEXICO: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 MEXICO: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 MEXICO: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 MEXICO: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 362 MEXICO: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 363 MEXICO: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 364 MEXICO: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 365 ARGENTINA: KEY MACROINDICATORS
  • TABLE 366 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 367 ARGENTINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 ARGENTINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 370 ARGENTINA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 371 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 373 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 374 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 375 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 377 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 384 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 385 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 386 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 387 MIDDLE EAST & AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 MIDDLE EAST & AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 MIDDLE EAST & AFRICA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 391 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 392 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 395 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 396 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 397 GCC COUNTRIES: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 GCC COUNTRIES: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 403 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 404 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 405 KINGDOM OF SAUDI ARABIA (KSA): KEY MACROINDICATORS
  • TABLE 406 KSA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 407 KSA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 KSA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 KSA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 KSA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 KSA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 412 KSA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 413 KSA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 414 KSA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 415 UNITED ARAB EMIRATES (UAE): KEY MACROINDICATORS
  • TABLE 416 UAE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 417 UAE: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 418 UAE: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 UAE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 UAE: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 421 UAE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 422 UAE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 423 UAE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 424 UAE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 425 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 426 OTHER GCC COUNTRIES: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 OTHER GCC COUNTRIES: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 428 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 429 OTHER GCC COUNTRIES: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 430 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 431 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 432 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 433 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 434 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 435 REST OF MIDDLE EAST & AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 436 REST OF MIDDLE EAST & AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 437 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 438 REST OF MIDDLE EAST & AFRICA: ENDECTOCIDES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 439 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 440 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 441 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024-2031 (USD MILLION)
  • TABLE 442 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 443 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET
  • TABLE 444 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION
  • TABLE 445 ANIMAL PARASITICIDES MARKET: REGION FOOTPRINT
  • TABLE 446 PRODUCT TYPE FOOTPRINT
  • TABLE 447 ANIMAL TYPE FOOTPRINT
  • TABLE 448 ANIMAL PARASITICIDES MARKET: LIST OF STARTUPS/SMES
  • TABLE 449 ANIMAL PARASITICIDES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 450 ANIMAL PARASITICIDES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2022-MAY 2026)
  • TABLE 451 ANIMAL PARASITICIDES MARKET: DEALS (JANUARY 2022-MAY 2026)
  • TABLE 452 ANIMAL PARASITICIDES MARKET: EXPANSIONS (JANUARY 2022-MAY 2026)
  • TABLE 453 ANIMAL PARASITICIDES MARKET: OTHER DEVELOPMENTS (JANUARY 2022-MAY 2026)
  • TABLE 454 ZOETIS INC.: COMPANY OVERVIEW
  • TABLE 455 ZOETIS INC.: PRODUCTS OFFERED
  • TABLE 456 ZOETIS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 457 ZOETIS, INC.: EXPANSIONS, JANUARY 2022- MAY 2026
  • TABLE 458 ZOETIS, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 459 MERCK & CO., INC.: COMPANY OVERVIEW
  • TABLE 460 MERCK & CO., INC.: PRODUCTS OFFERED
  • TABLE 461 MERCK & CO., INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 462 MERCK & CO., INC: DEALS, JANUARY 2022-MAY 2026
  • TABLE 463 MERCK & CO., INC: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 464 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 465 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 466 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 467 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2022-MAY 2026
  • TABLE 468 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 469 ELANCO: COMPANY OVERVIEW
  • TABLE 470 ELANCO: PRODUCTS OFFERED
  • TABLE 471 ELANCO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 472 ELANCO: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 473 ELANCO: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 474 VIRBAC: COMPANY OVERVIEW
  • TABLE 475 VIRBAC: PRODUCTS OFFERED
  • TABLE 476 VIRBAC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 477 VIRBAC: DEALS, JANUARY 2022-MAY 2026
  • TABLE 478 CEVA: COMPANY OVERVIEW
  • TABLE 479 CEVA: PRODUCTS OFFERED
  • TABLE 480 CEVA: DEALS, JANUARY 2022-MAY 2026
  • TABLE 481 CEVA: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 482 VETOQUINOL: COMPANY OVERVIEW
  • TABLE 483 VETOQUINOL: PRODUCTS OFFERED
  • TABLE 484 NORBROOK: COMPANY OVERVIEW
  • TABLE 485 NORBROOK: PRODUCTS OFFERED
  • TABLE 486 NORBROOK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022 - MAY 2026
  • TABLE 487 NORBROOK: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 488 BIMEDA CORPORATE: COMPANY OVERVIEW
  • TABLE 489 BIMEDA CORPORATE: PRODUCTS OFFERED
  • TABLE 490 BIMEDA CORPORATE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 491 BIMEDA CORPORATE: DEALS, JANUARY 2022-MAY 2026
  • TABLE 492 BIMEDA CORPORATE: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 493 KYORITSU SEIYAKU CORPORATION: COMPANY OVERVIEW
  • TABLE 494 KYORITSU SEIYAKU CORPORATION: PRODUCTS OFFERED
  • TABLE 495 KRKA, D. D., NOVO MESTO: COMPANY OVERVIEW
  • TABLE 496 KRKA, D. D., NOVO MESTO: PRODUCTS OFFERED
  • TABLE 497 ECO - ANIMAL HEALTH LTD.: COMPANY OVERVIEW
  • TABLE 498 ECO - ANIMAL HEALTH LTD.: PRODUCTS OFFERED
  • TABLE 499 ALIVIRA ANIMAL HEALTH LIMITED: COMPANY OVERVIEW
  • TABLE 500 ALIVIRA ANIMAL HEALTH LIMITED: PRODUCTS OFFERED
  • TABLE 501 ALIVIRA ANIMAL HEALTH LIMITED: DEALS, JANUARY 2022-MAY 2026
  • TABLE 502 OUROFINO SAUDE ANIMAL: COMPANY OVERVIEW
  • TABLE 503 OUROFINO SAUDE ANIMAL: PRODUCTS OFFERED
  • TABLE 504 HEBEI VEYONG PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 505 HEBEI VEYONG PHARMACEUTICAL CO., LTD: PRODUCTS OFFERED
  • TABLE 506 ANIMAL PARASITICIDES MARKET: ASSUMPTIONS ANALYSIS
  • TABLE 507 ANIMAL PARASITICIDES MARKET: RISK ASSESSMENT ANALYSIS

List of Figures

  • FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL ANIMAL PARASITICIDES MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL PARASITICIDES MARKET, 2022-2025
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ANIMAL PARASITICIDES MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN ANIMAL PARASITICIDES MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL PARASITICIDES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 8 INCREASING PET CARE EXPENDITURE TO DRIVE MARKET
  • FIGURE 9 ECTOPARASITICIDES AND CHINA DOMINATED MARKET IN 2025
  • FIGURE 10 ASIA PACIFIC TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 11 MARKET IN CHINA TO GROW AT HIGHEST CAGR
  • FIGURE 12 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 13 ANIMAL PARASITICIDES MARKET DYNAMICS
  • FIGURE 14 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION)
  • FIGURE 15 EUROPE: PET POPULATION, 2021-2023
  • FIGURE 16 ANIMAL PARASITICIDES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 ANIMAL PARASITICIDES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 18 ANIMAL PARASITICIDES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 AVERAGE SELLING PRICE OF ORAL ENDECTOCIDES, BY KEY PLAYER, 2025
  • FIGURE 20 AVERAGE SELLING PRICE OF ECTOPARASITICIDES, BY REGION, 2025
  • FIGURE 21 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 22 INVESTMENT/VENTURE CAPITAL SCENARIO IN ANIMAL PARASITICIDES MARKET, 2020-2024
  • FIGURE 23 ANIMAL PARASITICIDES: PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS
  • FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL PARASITICIDES (JANUARY 2015-MAY 2026)
  • FIGURE 25 AI USE CASES
  • FIGURE 26 AI DIAGNOSTIC PERFORMANCE IN PARASITE DETECTION
  • FIGURE 27 ANIMAL PARASITICIDES MARKET: DECISION-MAKING FACTORS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDE PRODUCTS
  • FIGURE 29 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • FIGURE 31 GLOBAL LIVESTOCK POPULATION BY SPECIES - FAO FAOSTAT, 2024 (BILLION ANIMALS)
  • FIGURE 32 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 33 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
  • FIGURE 34 NORTH AMERICA: PET POPULATION, 2024
  • FIGURE 35 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT
  • FIGURE 36 US: TOTAL PET HEALTH EXPENDITURE (2018-2024)
  • FIGURE 37 EUROPE: PET POPULATION (MILLION), 2023
  • FIGURE 38 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024
  • FIGURE 39 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024
  • FIGURE 40 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL PARASITICIDES MARKET (2023-2025)
  • FIGURE 42 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
  • FIGURE 43 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
  • FIGURE 44 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
  • FIGURE 45 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 46 ANIMAL PARASITICIDES MARKET: COMPANY FOOTPRINT
  • FIGURE 47 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 48 EV/EBITDA OF KEY VENDORS
  • FIGURE 49 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 51 ZOETIS INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 52 MERCK & CO., INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 53 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2025)
  • FIGURE 54 ELANCO: COMPANY SNAPSHOT (2025)
  • FIGURE 55 VIRBAC: COMPANY SNAPSHOT (2025)
  • FIGURE 56 VETOQUINOL: COMPANY SNAPSHOT (2025)
  • FIGURE 57 KRKA, D. D., NOVO MESTO: COMPANY SNAPSHOT (2025)
  • FIGURE 58 ECO - ANIMAL HEALTH LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 59 OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2025)
  • FIGURE 60 ANIMAL PARASITICIDES MARKET: RESEARCH DESIGN
  • FIGURE 61 PRIMARY SOURCES
  • FIGURE 62 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
  • FIGURE 63 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
  • FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 65 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 66 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS, INC.
  • FIGURE 67 REVENUE ANALYSIS OF TOP FIVE COMPANIES: ANIMAL PARASITICIDES MARKET (2025)
  • FIGURE 68 ANIMAL PARASITICIDES MARKET: DEMAND-SIDE ANALYSIS
  • FIGURE 69 TOP-DOWN APPROACH
  • FIGURE 70 BOTTOM-UP APPROACH
  • FIGURE 71 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ANIMAL PARASITICIDES MARKET (2026-2031)
  • FIGURE 72 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 73 MARKET DATA TRIANGULATION METHODOLOGY